Skip to content
Home/Companies/Biotech/Evexta Bio
Evexta Bio

Evexta Bio

Biotech·France·Active·13yr hold
Entry
2013
Hold
13yr
Status
Active

Who owns Evexta Bio?

Evexta Bio is a French Biotech company, currently owned by Truffle Capital since 2013.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Truffle Capital
Investor
Truffle Capital
Truffle Capital Legacy (pre-2019) · 2010 · VC

Key facts

HQFrance
SectorBiotech
StatusActive
Websitewww.evextabio.com

More from Truffle Capital Legacy (pre-2019)

Other portfolio companies in the same fund.

Holistick Medical
Holistick Medical
Active
MedTechFrance· 2017
NEW Generation Natural GAS
Active
EnergyFrance· 2017
Pharnext
Exited 2024
SoftwareFrance· 2017
to Pierre Bastid (Zaka) and Claude Berda (CBLux)
Retency
Exited 2024
SoftwareFrance· 2017
Skinosive
Skinosive
Active
HealthcareFrance· 2017
ACERDE
Acerde
Exited 2021
Deep TechFrance· 2016
to HEF Groupe

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Evexta Bio?

Evexta Bio is currently owned by Truffle Capital, through Truffle Capital Legacy (pre-2019), since 2013.

When did Truffle Capital acquire Evexta Bio?

Truffle Capital acquired Evexta Bio in 2013.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue